Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Immucell (ICCC) Other Gross PP&E Adjustments (2016 - 2025)

Historic Other Gross PP&E Adjustments for Immucell (ICCC) over the last 15 years, with Q3 2025 value amounting to $41.4 million.

  • Immucell's Other Gross PP&E Adjustments fell 22.18% to $41.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.4 million, marking a year-over-year decrease of 22.18%. This contributed to the annual value of $41.7 million for FY2024, which is 81.27% up from last year.
  • Per Immucell's latest filing, its Other Gross PP&E Adjustments stood at $41.4 million for Q3 2025, which was down 22.18% from $17.3 million recorded in Q2 2025.
  • Immucell's 5-year Other Gross PP&E Adjustments high stood at $42.7 million for Q1 2023, and its period low was $17.3 million during Q2 2025.
  • In the last 5 years, Immucell's Other Gross PP&E Adjustments had a median value of $41.4 million in 2023 and averaged $39.7 million.
  • As far as peak fluctuations go, Immucell's Other Gross PP&E Adjustments skyrocketed by 876.04% in 2022, and later plummeted by 5827.71% in 2025.
  • Quarter analysis of 5 years shows Immucell's Other Gross PP&E Adjustments stood at $39.7 million in 2021, then rose by 5.87% to $42.0 million in 2022, then dropped by 1.51% to $41.4 million in 2023, then grew by 0.81% to $41.7 million in 2024, then decreased by 0.75% to $41.4 million in 2025.
  • Its Other Gross PP&E Adjustments was $41.4 million in Q3 2025, compared to $17.3 million in Q2 2025 and $42.1 million in Q1 2025.